WhiteOak Capital Pharma and Healthcare Fund Direct Growth

WhiteOak Capital Pharma and Healthcare Fund Direct Growth

Equity
Sectoral
Very High Risk
1M
6M
1Y
All
NAV: 16 Jan '26
₹14.03
Min. SIP amount
₹100
Fund size
₹508.73 Cr
Expense ratio
0.66%

Return calculator

Monthly SIP
One time
Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns
1 year₹60,000₹61,631
+2.72%

Holdings (56)

NameSectorInstrumentsAssets
Sun Pharmaceutical Industries Ltd.HealthcareEquity10.91%
JB Chemicals & Pharmaceuticals Ltd.HealthcareEquity8.38%
Max Healthcare Institute Ltd.HealthcareEquity6.90%
Laurus Labs Ltd.HealthcareEquity5.44%
Fortis Healthcare Ltd.HealthcareEquity5.25%
Lupin Ltd.HealthcareEquity4.79%
Divi's Laboratories Ltd.HealthcareEquity4.50%
Cipla Ltd.HealthcareEquity3.90%
Alkem Laboratories Ltd.HealthcareEquity2.76%
Neuland Laboratories Ltd.HealthcareEquity2.49%
Krishna Institute of Medical Sciences LtdHealthcareEquity2.35%
Ajanta Pharma Ltd.HealthcareEquity2.27%
Sai Life Sciences Ltd.HealthcareEquity2.16%
Shaily Engineering Plastics Ltd.ChemicalsEquity2.07%
Vijaya Diagnostic Centre Ltd.HealthcareEquity2.01%
Abbott India Ltd.HealthcareEquity1.91%
Apollo Hospitals Enterprise Ltd.HealthcareEquity1.77%
Dr. Reddy's Laboratories Ltd.HealthcareFutures1.71%
Narayana Hrudayalaya Ltd.HealthcareEquity1.70%
Piramal Pharma Ltd.HealthcareFutures1.55%
Pfizer Ltd.HealthcareEquity1.47%
Astrazeneca Pharma India Ltd.HealthcareEquity1.47%
Emcure Pharmaceuticals Ltd.HealthcareEquity1.40%
Kovai Medical Center & Hospital Ltd.HealthcareEquity1.39%
Eris Lifesciences Ltd.HealthcareEquity1.34%
Zota Health Care Ltd.HealthcareEquity1.34%
Thyrocare Technologies Ltd.HealthcareEquity1.29%
Acutaas Chemicals Ltd.HealthcareEquity1.25%
Sudeep Pharma Ltd.HealthcareEquity1.21%
Navin Fluorine International Ltd.ChemicalsEquity1.18%
Poly Medicure Ltd.HealthcareEquity1.12%
Strides Pharma Science Ltd.HealthcareEquity1.10%
Dr Agarwals Eye Hospital Ltd.HealthcareEquity0.95%
Aether Industries Ltd.ChemicalsEquity0.93%
Divi's Laboratories Ltd.HealthcareFutures0.92%
Jupiter Life Line Hospitals Ltd.HealthcareEquity0.92%
Supriya Lifescience Ltd.HealthcareEquity0.85%
Reserve Bank of IndiaFinancialT-Bills0.78%
Anthem Biosciences Ltd.HealthcareEquity0.75%
Shilpa Medicare Ltd.HealthcareEquity0.52%
CORONA Remedies Ltd.HealthcareEquity0.51%
Dr. Reddy's Laboratories Ltd.HealthcareEquity0.49%
Reserve Bank of IndiaFinancialT-Bills0.43%
Reserve Bank of IndiaFinancialT-Bills0.40%
Orchid Pharma Ltd.HealthcareEquity0.33%
Apollo Hospitals Enterprise Ltd.HealthcareFutures0.33%
Piramal Pharma Ltd.HealthcareEquity0.28%
Max Healthcare Institute Ltd.HealthcareFutures0.27%
Reserve Bank of IndiaFinancialT-Bills0.20%
Reserve Bank of IndiaFinancialT-Bills0.19%
Reserve Bank of IndiaFinancialT-Bills0.18%
Fortis Healthcare Ltd.HealthcareFutures0.18%
Reserve Bank of IndiaFinancialT-Bills0.14%
Reserve Bank of IndiaFinancialT-Bills0.12%
Reserve Bank of IndiaFinancialT-Bills0.08%
Reserve Bank of IndiaFinancialT-Bills0.08%
See All

Minimum investments

Min. for 1st investment
₹500
Min. for 2nd investment
₹500
Min. for SIP
₹100

Returns and rankings

Annualised returns
Absolute returns
Name3M6M1YAll
Fund returns-1.4%+0.2%+6.1%+41.7%
Category average (Equity Sectoral)-----2.1%--
Rank (Equity Sectoral)1122--

Exit load, stamp duty and tax

Exit load

Exit load of 1%, if redeemed within 1 months.

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data

Fund management

About WhiteOak Capital Pharma and Healthcare Fund Direct Growth

WhiteOak Capital Pharma and Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by WhiteOak Capital Mutual Fund. This scheme was made available to investors on 03 Jul 2018. Piyush Baranwal is the Current Fund Manager of WhiteOak Capital Pharma and Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹31,996 Cr and the Latest NAV as of 16 Jan 2026 is ₹14.03. The WhiteOak Capital Pharma and Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹500. Exit load of 1%, if redeemed within 1 months. ;

Investment Objective

The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Fund benchmarkBSE Healthcare Total Return Index

Fund house

Rank (total assets)NA
Total AUM₹31,996.10 Cr
Date of Incorporation03 Jul 2018
Phone180030003060
E-mailNA
Launch Date03 Jul 2018
AddressUnit No. B4, 6th Floor,Cnergy, Appasaheb Marathe Marg,Prabhadevi Mumbai 400025
CustodianDeutsche Bank
Registrar & Transfer AgentCams
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,